piribedil has been researched along with Dyskinesia, Drug-Induced in 10 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aims of this study were therefore (1) to investigate the anti-dyskinetic effects of piribedil on L-DOPA-induced contralateral turning behaviour, locomotive dyskinesias (LD), axial dystonia (AD), orolingual dyskinesia (OD) and forelimb dyskinesia (FD) and (2) to compare these effects to the α(2) adrenoceptor antagonist, idazoxan, or the α(2) adrenoceptor agonist, clonidine." | 3.79 | The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of α(2) adrenergic mechanisms. ( Gerlach, M; Halley, P; Riederer, P; van den Buuse, M, 2013) |
| "Electromyographic (EMG) activity of abnormal involuntary movements and their modifications after Piribedil, a dopaminergic agonist, were analysed in patients presenting with tremor or tardive dyskinesia induced by treatment with neuroleptics." | 3.67 | EMG patterns in abnormal involuntary movements induced by neuroleptics. ( Bathien, N; Koutlidis, RM; Rondot, P, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedorova, NV | 1 |
| Kulua, TK | 1 |
| Gubanova, ЕN | 1 |
| Lane, EL | 1 |
| Dunnett, SB | 1 |
| Gerlach, M | 1 |
| Halley, P | 1 |
| Riederer, P | 1 |
| van den Buuse, M | 1 |
| Smith, LA | 1 |
| Tel, BC | 1 |
| Jackson, MJ | 1 |
| Hansard, MJ | 1 |
| Braceras, R | 1 |
| Bonhomme, C | 1 |
| Chezaubernard, C | 1 |
| Del Signore, S | 1 |
| Rose, S | 1 |
| Jenner, P | 1 |
| Bathien, N | 2 |
| Rondot, P | 2 |
| Koutlidis, RM | 2 |
| Cools, AR | 1 |
| Offermeier, J | 1 |
| van Rooyen, JM | 1 |
| Broekkamp, CL | 1 |
| Boraud, T | 1 |
| Bezard, E | 1 |
| Bioulac, B | 1 |
| Gross, CE | 1 |
1 review available for piribedil and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Mesolimbic system and tardive dyskinesia: new perspectives for therapy.
Topics: Antipsychotic Agents; Corpus Striatum; Dyskinesia, Drug-Induced; Humans; Limbic System; Neural Pathw | 1983 |
9 other studies available for piribedil and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
[The use of piribedil in early and late stages of Parkinson's disease].
Topics: Antiparkinson Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Middle | 2015 |
Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-I | 2010 |
The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of α(2) adrenergic mechanisms.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; An | 2013 |
Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Arousal; Callithrix; Ca | 2002 |
[Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
Topics: Antipsychotic Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Electromyography; Humans; Levo | 1981 |
EMG patterns in abnormal involuntary movements induced by neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Electromyography; Female; Humans; Male; | 1984 |
Dopamine inhibitory and excitatory systems in tardive dyskinesias.
Topics: Animals; Apomorphine; Disease Models, Animal; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced | 1983 |
Stereotypy and dyskinesias provoked in cats differentiate directly and indirectly-acting psychomotor stimulants.
Topics: Animals; Apomorphine; Cats; Dextroamphetamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Nom | 1982 |
Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzaze | 2001 |